Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

DIABETESMINE UNIVERSITY 2019: Cam Med EVOpump DEMO

121 views

Published on

A first look at the flexible EVOpump insulin pump under development, presented at the DiabetesMine D-Data ExChange in Fall 2019.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

DIABETESMINE UNIVERSITY 2019: Cam Med EVOpump DEMO

  1. 1. Flexible Insulin delivery: Allowing you to get back to life sooner.
  2. 2. 2 Age 11: Diagnosed T1D: MDI therapy Age 23: Pump Therapy: MM 506– 523 Age 45: Patch pump Age 49: What’s next? The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only
  3. 3. How it works 1) evoPump is primed & applied onto body The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only
  4. 4. How it works 1) evoPump is primed & applied onto body The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only 2) Electrodes pass current to electrolyte -> electrolysis
  5. 5. How it works 1) evoPump is primed & applied onto body The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only 2) Electrodes pass current to electrolyte -> electrolysis 3) Gas bubbles are generated, controlling delivery rate
  6. 6. How it works 1) evoPump is primed & applied onto body The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only 2) Electrodes pass current to electrolyte -> electrolysis 3) Gas bubbles are generated, controlling delivery rate 4) This gas pressure deflects a membrane that separates electrolyte from medication
  7. 7. How it works 1) evoPump is primed & applied onto body The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only 2) Electrodes pass current to electrolyte -> electrolysis 3) Gas bubbles are generated, controlling delivery rate 4) This gas pressure deflects a membrane that separates electrolyte from medication 5) Membrane deflection displaces drug from reservoirs to cannula
  8. 8. Putting it on 1) Fill Insulin into the EvoPump 2) Remove adhesive release liner 3) Place EvoPump on body & rotate applicator. Pull the applicator up & off, & you’re ready to go! Fill Remove Place & Rotate The EvoPump and the Evo-connected handheld have not received regulatory clearance. For investigational use only.
  9. 9. Features 1 2 3 4 Ultra-thin Patch-like feel Multiple reservoirs Actively-controllable, Bluetooth-enabled 5Simpler to manufacture Disappears underneath clothing Easy transition to wearables from a pen Potential for multiple drugs Allows closed-loop delivery & active titration, improving effectiveness and reducing side effects The luxury of a wearable at the cost of a pen! EvoPump: Easy to use with minimal steps. Benefits TheEvoPumpandtheEvoconnectedhandheldhavenotreceived regulatoryclearance.Forinvestigationaluseonly
  10. 10. Bring your own device / algorithm Secure & encrypted Bluetooth connection Alternate controller enabled infusion pump (ACE)* *pending FDA submission and approval
  11. 11. • “The ease of use and slim design could substantially reduce the burden of living with Type 1.” – JDRF Scientist • “This will be huge hit with patients.” – Director of Pump Programs at Joslin Diabetes Center • “It doesn’t seem like a medical device; it’s like a patch, not an insulin pump.” – Attorney, Medtronic 630G user • “I love the flexibility. It’s so small. It’s amazing – Mother of three, Omnipod user What do users and key opinion leaders think? Just ask them! The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only
  12. 12. EvoPump Development Timeline Initial seed funding JDRF funding, JLABS entry 2017 2018 Proof-of-concept demonstration with 2-reservoir alpha prototype Complete full-scale beta prototype, demonstrating high-precision delivery, insulin compatibility and delivery into tissue 2019 2020 Complete gamma prototype system for human use and submit for IDE Demonstrate interoperability First-in-human clinical study 2021 The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only
  13. 13. Venture Recognition & Funding 2014 Gold Prize Winner 2014 Winner Prize for Technology in Space 2015 Awardee Universal Partnership Grant 2017/19 Startup Grant 2017 Awardee 2017 Grant Recipient 2017 Recipient 2017 Grant Recipient 2018 3rd Place Winner Active development agreements with two pharmaceutical partners The EvoPump and the Evo connected handheld have not received regulatory clearance. For investigational use only

×